Source: Annual Congress 2011 - Biomarkers and outcomes of community-acquired pneumonia
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
E. Mincholé, A. Lasierra, A. L. Simón, S. Fandos, M. A. Ruiz, V. Moya, F. De Pablo, S. Bello (Zaragoza, Spain). Biomarkers to discriminate bacterial, viral and mixed community acquired pneumonia (CAP). Eur Respir J 2011; 38: Suppl. 55, 1466

Member's Comments

No comment yet.

Related content which might interest you: Biomarkers and community acquired pneumonia (CAP) severity Source: Annual Congress 2010 - The prognosis of community-acquired pneumonia: old and new markers of severity Year: 2010 Biomarkers and community acquired pneumonia (CAP) severity Source: Annual Congress 2011 - Biomarkers and outcomes of community-acquired pneumonia Year: 2011 Virusologic research in healthy persons of closed collectives Source: Annual Congress 2005 - Host-pathogen interaction in respiratory virus infections Year: 2005 Factors related to obtain an etiological diagnosis in community acquired pneumonia (CAP) Source: Annual Congress 2007 - Prognostic laboratory tests in community-acquired pneumonia Year: 2007 I-ROAD could be efficient in predicting severity of community acquired pneumonia (CAP) or healthcare-associated-pneumonia(HCAP) Source: Annual Congress 2010 - Healthcare-associated pneumonia: ventilator-associated pneumonia and pneumonia in hospitalised patients Year: 2010 Defining stability in pneumonia and the non-responding pneumonia Source: Annual Congress 2005 - Outcome in severe pneumonia Year: 2005 The role of viral infection in the progression of community-acquired pneumonia (CAP) Source: International Congress 2015 – Viral infections: basic research and clinical perspective Year: 2015 Characterization of community acquired pneumonia (CAP) with severe sepsis at diagnosis Source: Annual Congress 2012 - Epidemiology: risk factors and prognosis in respiratory infections Year: 2012 Role of viruses, alone and in association with bacteria, in adults hospitalized with community-acquired pneumonia (CAP) Source: Annual Congress 2011 - Aetiology, diagnosis and outcomes in community-acquired pneumonia Year: 2011 Initial and persistent inflammatory response in treatment failure in community-acquired pneumonia Source: Annual Congress 2007 - Prognostic laboratory tests in community-acquired pneumonia Year: 2007 Community acquired pneumonia (CAP) mortality and biomarkers Source: Annual Congress 2011 - Biomarkers and outcomes of community-acquired pneumonia Year: 2011 Biological markers in hospitalised patients with community acquired pneumonia (CAP) Source: Annual Congress 2010 - The spectrum of lower respiratory tract infections: risk factors of poor outcome and diagnostic tools Year: 2010 Immunity status of community acquired pneumonia (CAP) young patients according concomitant cytomegalovirus persistence (CMVP) Source: International Congress 2019 – Host-microbe interactions in lung disease and exacerbations Year: 2019 Viral and mixed virus-bacteria community-acquired pneumonia (CAP) in hospitalized adults Source: Annual Congress 2009 - Aetiology and diagnosis of lower respiratory tract infections Year: 2009 The severity of Pneumocystis pneumonia without human immunodeficiency virus infection (non-HIV PCP) might be underestimated by conventional diagnostic rules for community-acquired pneumonia (CAP) Source: Annual Congress 2010 - Aetiology of lower respiratory tract infections and treatment in special situations Year: 2010 Cardiac diseases in patients with community acquired pneumonia (CAP) Source: Annual Congress 2012 - Epidemiology: risk factors and prognosis in respiratory infections Year: 2012 Health care associated pneumonia (HCAP) and community acquired pneumonia (CAP): Are they different diseases? Source: Annual Congress 2010 - Healthcare-associated pneumonia: ventilator-associated pneumonia and pneumonia in hospitalised patients Year: 2010 Clinical stability in patients with community- acquired pneumonia (CAP) Source: Annual Congress 2011 - New aspects in prevention and treatment of community-acquired pneumonia and lower respiratory tract infections Year: 2011 A prospective comparison of nursing home acquired pneumonia (NAP) with community acquired pneumonia (CAP) Source: Eur Respir J 2005; 26: Suppl. 49, 257s Year: 2005 Studying lung inflammatory biomarkers using non-invasive methods in patients with community acquired pneumonia (CAP) Source: Eur Respir J 2002; 20: Suppl. 38, 443s Year: 2002